Skip to main content

Ildong Holdings Co., Ltd. (000230.KS)

KSC Healthcare Drug Manufacturers - Specialty & GenericView data quality →
57.0Fair

ValueMarkers Composite Index

Top 63%#16,392 of 44,714
Undervalued

95% below intrinsic value ($133)

UndervaluedFair ValueOvervalued
Piotroski
7/9
Strong
Beneish
-2.52
Low Risk
Altman
0.56
Distress
DCF Value
$133
Undervalued
ROIC
1.5%
Low
P/E
8.1
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Ildong Holdings Co., Ltd. (000230.KS) — VMCI valuation read

Composite valuation read on 000230.KS: VMCI 57/100 against a Healthcare sector median of 50. The 7-point above-median print is the headline number for Ildong Holdings Co., Ltd., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for 000230.KS: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on 000230.KS: 000230.KS trades at 27.0x earnings, 50% above the Healthcare median of 18.0x; ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%); net debt to EBITDA of -1.5x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

000230.KS fell 1.2% over the trailing 7 days, with a +0.8% read on a 30-day basis.

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It also engages in the research and manufacture of health foods and ingredients, as well as offers hyaluronic acid for use in drugs, medical devices, and cosmetics; and various medical devices for beauty, cosmetic-surgery, and antiaging applications. In addition, the company distributes medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products through online. Further, it offers beauty and cosmetic surgery services; and pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions, as well as engages in advertising business. The company was formerly known as Ildong Pharmaceutical Co., Ltd. and changed its name to Ildong Holdings Co., Ltd. in August 2016. Ildong Holdings Co., Ltd. was founded in 1941 and is based in Seoul, South Korea.

CEO: Woongseop Yoon80 employeesKRwww.ildongholdings.co.kr

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 000230.KS’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.